Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Washing can prevent cancer from lubricating oils, extreme body temperatures need more study, Sulfomid is not recognized, no reliable diphtheria carrier treatment except surgery, eyelid injuries should heal before repair, heterophile antibody test is specific for mononucleosis, chlorine inhalations for colds are outdated, and wheat germ is safe.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

Immunizing goats against melatonin can temporarily change their cashmere growth cycles and increase fleece production.

Pemphigus patients with alopecia have more severe and treatment-resistant disease.

Immuno-cosmeceuticals from chicken egg yolk can effectively repair and improve damaged hair.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Hashimoto's thyroiditis can sometimes change to Graves' disease, so patients need careful monitoring.

Hair becomes less stiff as we age because of a decrease in zinc, which is linked to lower levels of the protein TG3.

Many patients with cutaneous lupus erythematosus experience hair loss and nail problems, which are important for diagnosis and treatment.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Dr. Jia-You Fang is a highly experienced researcher in drug delivery and related fields, with numerous publications and international collaborations.

Male hormones promote hair cell growth by using a growth factor from nearby skin cells.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Dupilumab can both heal and cause hair loss.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

EF and PXE not closely related.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Omalizumab may cause hair loss.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Panitumumab can cause excessive ear hair growth.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.